Create a Healthcare Data Test Environment
June 19, 2014
Tip 15 in the Interoperability Tip Series Once you’ve developed a test plan and test scenarios, you need to configure your interface in a test
Tip 15 in the Interoperability Tip Series Once you’ve developed a test plan and test scenarios, you need to configure your interface in a test
Tip 14 in the Interoperability Tip Series In last week’s tip, we talked about capturing workflows. Here’s why. Before you can conduct any interface testing,
Tip 13 in the Interoperability Tip Series Last week in Tip 12, we covered when, why, and what to test when you’re working with interfaces.
Tip 12 in the Interoperability Tip Series In tips from the past few weeks, we covered two requirements-related artifacts analysts must create: 1) profiles or
Tip 11 in the Interoperability Tip Series Last week, you learned about doing a gap analysis – mapping differences between the systems you’re interfacing. Today,
Tip 10 in the Interoperability Tip Series In the previous tip, we covered specifications. Another key requirements or scoping document you’ll need is a gap
Tip 9 in the Interoperability Tip Series In Tip 8, we explained what an HL7 interface specification should include. In this tip, learn how to
Tip 8 in the Interoperability Tip Series Critical Elements in an HL7 Interface Specification These are critical elements a developer needs to create a interface
Tip 7 in the Interoperability Tip Series Communicating These Needs to Leadership These are the most important assets you’ll need when you’re working on creating
Tip 6 in the Interoperability Tip Series This tip is for hospital or provider analysts and team leads. You’ve got a firm grasp of the
NORTH AMERICA: +1 (877)-872-0027
WORLD: 1-418-872-4000
EMAIL: info@caristix.com
ASIA-PACIFIC
DENIS CANTIN
T: +61418441388
denis.cantin@caristix.com
NORTH AMERICA & EUROPE
JEAN-LUC MORIN
T: 418 872-4000
jeanluc.morin@caristix.com
HL7® / FHIR® are a registered trademarks of Health Level Seven International. The use of this trademark does not constitute an endorsement by HL7.